Timothy P Walbert Horizon Therapeutics Public LTD CO (HZNP) insider trading activity

Timothy P Walbert is Chairman, President and CEO of Horizon Therapeutics Public Ltd Co. Currently has a direct ownership of 0 shares of HZNP, which is worth approximately $0. The most recent transaction as insider was on Oct 15, 2019, when has been sold 311,869 shares (Ordinary Shares) at a price of $5.01 per share, resulting in proceeds of $1,562,464. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Timothy P Walbert Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 15 2019	BUY Exercise of conversion of derivative security	$1,562,464 $5.01 p/Share	311,869 Added 22.13%	1,097,165 Ordinary Shares
Aug 30 2019	SELL Open market or private sale	$70,000 $28.0 p/Share	2,500 Reduced 0.32%	785,296 Ordinary Shares
Aug 22 2019	SELL Open market or private sale	$55,552 $28.0 p/Share	1,984 Reduced 0.25%	787,796 Ordinary Shares
Aug 21 2019	SELL Open market or private sale	$1,591,976 $28.01 p/Share	56,836 Reduced 6.71%	789,780 Ordinary Shares
Mar 23 2019	SELL Payment of exercise price or tax liability	$1,486,265 $26.84 p/Share	55,375 Reduced 6.16%	844,246 Ordinary Shares
Mar 23 2019	BUY Exercise of conversion of derivative security	-	125,000 Added 12.2%	899,621 Ordinary Shares
Feb 20 2019	SELL Payment of exercise price or tax liability	$1,608,112 $21.54 p/Share	74,657 Reduced 8.79%	774,621 Ordinary Shares

Feb 20 2019	BUY Grant, award, or other acquisition	-	168,521 Added 16.56%	849,278 Ordinary Shares
Jan 05 2019	SELL Payment of exercise price or tax liability	$1,388,151 $20.39 p/Share	68,080 Reduced 9.09%	680,757 Ordinary Shares
Jan 05 2019	BUY Exercise of conversion of derivative security	-	152,966 Added 16.96%	748,837 Ordinary Shares
Nov 19 2018	BUY Exercise of conversion of derivative security	$249,503 $5.01 p/Share	49,801 Added 7.71%	595,871 Ordinary Shares
Nov 14 2018	SELL Open market or private sale	$8,795,795 $21.54 p/Share	408,347 Reduced 42.78%	546,070 Ordinary Shares
Nov 14 2018	BUY Exercise of conversion of derivative security	$3,144,272 $7.7 p/Share	408,347 Added 29.96%	954,417 Ordinary Shares
Jun 01 2018	SELL Open market or private sale	$1,347,818 $16.17 p/Share	83,353 Reduced 13.24%	546,070 Ordinary Shares
Jun 01 2018	BUY Exercise of conversion of derivative security	$869,372 $10.43 p/Share	83,353 Added 11.69%	629,423 Ordinary Shares
Mar 23 2018	SELL Payment of exercise price or tax liability	$767,497 $13.86 p/Share	55,375 Reduced 9.24%	543,700 Ordinary Shares
Mar 23 2018	BUY Exercise of conversion of derivative security	-	125,000 Added 17.26%	599,075 Ordinary Shares
Jan 02 2018	SELL Payment of exercise price or tax liability	$354,863 $15.02 p/Share	23,626 Reduced 4.75%	474,075 Ordinary Shares
Jan 02 2018	BUY Exercise of conversion of derivative security	-	49,500 Added 9.05%	497,701 Ordinary Shares
Mar 23 2017	SELL Payment of exercise price or tax liability	$831,740 $14.56 p/Share	57,125 Reduced 11.34%	446,721 Ordinary Shares
Mar 23 2017	BUY Exercise of conversion of derivative security	-	125,000 Added 19.88%	503,846 Ordinary Shares
Jan 02 2017	SELL Payment of exercise price or tax liability	$610,035 $16.18 p/Share	37,703 Reduced 9.05%	378,846 Ordinary Shares
Jan 02 2017	BUY Exercise of conversion of derivative security	-	81,675 Added 16.39%	416,549 Ordinary Shares
Aug 18 2016	BUY Exercise of conversion of derivative security	$19,992 $2.4 p/Share	8,330 Added 2.43%	334,874 Ordinary Shares
Mar 23 2016	SELL Payment of exercise price or tax liability	$932,280 $16.32 p/Share	57,125 Reduced 14.97%	324,493 Ordinary Shares

Also insider at

XCUR

EXICURE, INC. Healthcare

Director

AUPH

Aurinia Pharmaceuticals Inc. Healthcare

Director

IPSC

Century Therapeutics, Inc. Healthcare

Director

MIRM

Mirum Pharmaceuticals, Inc. Healthcare

SGMT

Sagimet Biosciences Inc.

Director

TPW